PTHS
Pelthos Therapeutics Inc.
20.50$
-0.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +6.6% | +29.0% | -11.5% | – | |
| – | – | +56.9% | +12.7% | +2.5% | -8.4% | -14.9% | +568.1% | -34.9% | +6.1% | +44.7% | – | |
| – | -160.2% | – | – | -51.9% | +16.2% | +220.8% | -307.7% | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | -100.0% | – | +96.0% | -99.0% | – | |
| – | – | – | – | – | – | – | – | -389.6% | -97.6% | -99.0% | – | |
| – | – | -100.0% | – | -100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | -82.9% | – | +50.0% | +6,995.2% | -135.7% | – | -100.0% | – | |
| – | +1,216.4% | -72.0% | -161.3% | -92.7% | – | +50.0% | +7,017.9% | -32.5% | +52.7% | -100.0% | – | |
| – | +4,891.3% | -137.2% | – | – | – | – | – | -73.3% | +276.7% | -154.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.